Positron, Disease Management to develop heart disease management tool

Positron Corporation and Disease Management have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.??

The product will include a heart disease pre-test risk calculator; a Coronary Disease Reversal and Prevention practice management program; a web-based, patient-centric, disease-reversal and life-style modification program; an interpreting and referring physician portal as well as a cost-efficacy and patient-outcomes tracker, according to the Houston-based Positron.??

“The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payors, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer,” said Joseph G. Oliverio, president of Positron.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup